Green Tea (Camellia sinensis) Extract is Effective Against Biofilms of Staphylococcus aureus and Pseudomonas aeruginosa, and Interferes on the Activity of Antimicrobial Drugs
Marcus Vinícius Dias Dias-Souza, Gustavo José da Costa, Renan Martins dos Santos, Isabela Penna Ceravolo, Gabriel Pimenta Freire
{"title":"Green Tea (Camellia sinensis) Extract is Effective Against Biofilms of Staphylococcus aureus and Pseudomonas aeruginosa, and Interferes on the Activity of Antimicrobial Drugs","authors":"Marcus Vinícius Dias Dias-Souza, Gustavo José da Costa, Renan Martins dos Santos, Isabela Penna Ceravolo, Gabriel Pimenta Freire","doi":"10.2174/2666862901666230419092405","DOIUrl":null,"url":null,"abstract":"\n\nGiven the lack of options for treating infectious diseases, it is urgent to\nexplore new antimicrobials. Plant food historically represents relevant sources of antimicrobial\nmolecules.\n\n\n\nHere, we show that green tea can eradicate biofilms and planktonic cells of clinical\nisolates of Staphylococcus aureus and Pseudomonas aeruginosa.\n\n\n\n\nWe conducted in vitro antimicrobial activity tests (MIC, MBC, MBEC). Cytotoxicity\ntests were conducted using BGM cells. We used UPLC and GC-MS to detect flavonoids and other relevant phytomolecules. The antioxidant potential was assessed using the β-carotene bleaching\ntest. The extract was combined to clinically relevant antimicrobial drugs in vitro to investigate\npossible synergism or antagonism.\n\n\n\n\nTo the best of our knowledge, MIC values are among the lowest ever described for the\nalcoholic extract (8 µg/mL). The extract presented elevated antioxidant potential and was not\ntoxic to BGM cells. When the extract was combined to clinically relevant antimicrobial drugs,\nstatistically significant antagonism was frequent for the drugs used against S. aureus isolates,\nwhilst significant synergism was observed for some drugs used against P. aeruginosa isolates.\n\n\n\nOur data open doors for exploring isolated molecules from green tea extract against\nbacterial biofilms, and for developing formulations for clinical treatments.\n","PeriodicalId":251049,"journal":{"name":"Current Functional Foods","volume":"39 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Functional Foods","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/2666862901666230419092405","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Given the lack of options for treating infectious diseases, it is urgent to
explore new antimicrobials. Plant food historically represents relevant sources of antimicrobial
molecules.
Here, we show that green tea can eradicate biofilms and planktonic cells of clinical
isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
We conducted in vitro antimicrobial activity tests (MIC, MBC, MBEC). Cytotoxicity
tests were conducted using BGM cells. We used UPLC and GC-MS to detect flavonoids and other relevant phytomolecules. The antioxidant potential was assessed using the β-carotene bleaching
test. The extract was combined to clinically relevant antimicrobial drugs in vitro to investigate
possible synergism or antagonism.
To the best of our knowledge, MIC values are among the lowest ever described for the
alcoholic extract (8 µg/mL). The extract presented elevated antioxidant potential and was not
toxic to BGM cells. When the extract was combined to clinically relevant antimicrobial drugs,
statistically significant antagonism was frequent for the drugs used against S. aureus isolates,
whilst significant synergism was observed for some drugs used against P. aeruginosa isolates.
Our data open doors for exploring isolated molecules from green tea extract against
bacterial biofilms, and for developing formulations for clinical treatments.